Home
#Global Trends
#Vietnam
#M&A
#Regulations
#Knowledge
Newletter
Events

Home
#Global Trends
#Vietnam
#M&A
#Regulations
#Knowledge
Newletter
Events

Category: Uncategorized

Late-Stage Product Lifecycle Aggregation: Eli Lilly Divests Mainland China Commercial Rights for Blockbuster Verzenios to Innovent

01/07/2026 Published by Pharma Biz

Key Development Global biopharmaceutical leader Eli Lilly has formally executed a definitive strategic agreement transferring the mainland China commercialization rights... Read more

Tags: #Global Trends

Geopolitical Biopharma Friction: U.S. House Committee Launches National Security Probe into Merck and AbbVie Clinical Trials in China

01/07/2026 Published by Pharma Biz

Key Development The chair of the U.S. House Select Committee on the Strategic Competition Between the United States and the... Read more

Category: Uncategorized

Tags: #Global Trends

Geopolitical Biopharma Friction: U.S. House Committee Launches National Security Probe into Merck and AbbVie Clinical Trials in China

01/07/2026 Published by Pharma Biz

Key Development The chair of the U.S. House Select Committee on the Strategic Competition Between the United States and the... Read more

Category: Uncategorized

Tags: #Global Trends

Rebounding in the DLBCL Matrix: AbbVie and Genmab Liquidate Monotherapy Setbacks with Landmark Epkinly Combo Victory

01/07/2026 Published by Pharma Biz

Key Development Biopharmaceutical aggregators AbbVie and Genmab have jointly released positive top-line data from their definitive Phase III Epcore DLBCL-4... Read more

Category: Uncategorized

Tags: #Global Trends

Compliance Risk Governance: AstraZeneca Deploys $34 Million to Settle Texas ‘Free Nurses’ Medicaid Kickback Litigation

01/07/2026 Published by Pharma Biz

Key Development Global biopharmaceutical enterprise AstraZeneca has formally agreed to a $34 million financial settlement to resolve a high-profile civil... Read more

Category: Uncategorized

Tags: #Global Trends

Enforcing Regional Safety Standards: Drug Administration of Vietnam Decrees Nationwide Recall of 4 Anti-Dandruff Shampoos Containing Banned Ingredient Clotrimazole

01/07/2026 Published by Pharma Biz

Key Development The Drug Administration of Vietnam (DAV), operating under the Ministry of Health, has formally issued an emergency regulatory... Read more

Category: Uncategorized

Tags: #Vietnam

Post-M&A Executive Realignment: China’s Livzon Group Assumes Control of Imexpharm (IMP), Directing a 6% Cash Dividend

01/07/2026 Published by Pharma Biz

Key Development Imexpharm Pharmaceutical Joint Stock Company (Ticker: IMP)—a premier listed pharmaceutical manufacturer on the Vietnamese equity markets—has officially released... Read more

Category: Uncategorized

Tags: #Vietnam

Biopharma Technical Standardization: Ministry of Health Launches Vietnamese Pharmacopoeia VI to Revolutionize Quality Control Infrastructure

01/07/2026 Published by Pharma Biz

Key Development The Ministry of Health of Vietnam has officially announced the implementation of the Vietnamese Pharmacopoeia VI (authorized under... Read more

Category: Uncategorized

Tags: #Vietnam

Manufacturing Compliance Enforcement: Drug Administration of Vietnam Orders Nationwide Recall of Hoa Xu Lang Herbal Hair Care Products

01/07/2026 Published by Pharma Biz

Key Development The Drug Administration of Vietnam (DAV), operating under the Ministry of Health, has formally issued a dynamic regulatory... Read more

Category: Uncategorized

Tags: #Vietnam

Posts pagination

Previous page Page 1 … Page 64 Page 65 Page 66 … Page 226 Next page

Facebook

Map

Workday: Monday to Friday
Working hours: 8am to 5pm
Address: 8th floor, Hyco 4 building, 205A Nguyen Xi Street, Binh Thanh Ward, HCMC

Please enable JavaScript in your browser to complete this form.

Email *

Get Your Weekly Market Insights Stay informed on Vietnam's market & Healthcare Alliance updates

Category: Uncategorized

Facebook

Map

Online Members